2nd Quarter - Report

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for GRACEWAY PHARMACEUTICALS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2008 $80,000 Replaced
2nd Quarter - Amendment Feb 11, 2009 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Extension of time to transition asthma inhaler from CFC to non-CFC form.

LobbyistCovered position, as disclosed
KATHLEEN M MCAULIFFE New Minority Leader Richard A. Gephardt
CANDIDA PEROTTI WOLFF New for Legislative Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.